David C. Newitt

Medicine · Health Sciences

44h-index5.9kcitations140works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

MRI in cancer diagnosis(72), Radiomics and Machine Learning in Medical Imaging(56), Bone health and osteoporosis research(40), Medical Imaging Techniques and Applications(35), Advanced Neuroimaging Techniques and Applications(34)

Publications140 total

Effects of multi-vendor gradient non-linearity correction on breast tumor ADC measurements in the ACRIN 6698 trial
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Standardized QC procedure for vendor-implemented ADC correction of gradient nonlinearity bias in multi-center clinical trials
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Image quality ranking for breast diffusion-weighted MRI in a multi-center clinical trial
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Automated breast tumor segmentation in DWI using multi-modality image registration: a feasibility study using multi-center data
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Longitudinal assessment of variability in a multicenter MRI QC program using the CaliberMRI breast phantom: protocol adherence and ADC values
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2024
Inter-reader variability in apparent diffusion coefficient measurements for assessment of breast cancer response to neoadjuvant therapy
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2023
Predicting response to neoadjuvant therapy using tumor morphologic features on breast MRI
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2023
Early treatment re-direction based on functional tumor volume at 3 and 6-week MRI for breast cancer patients undergoing neoadjuvant chemotherapy
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2023
Multi-site, longitudinal assessment of quantitative breast MRI variability using the CaliberMRI phantom
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2023
Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy
Communications Medicine·2023· 10 citedOpen Access
Abstract PD16-07: Association of MRI morphologic phenotype from unsupervised learning with breast cancer subtypes and treatment response
Cancer Research·2023
Abstract P6-01-33: Diffusion-weighted magnetic resonance imaging for subtype-specific prediction of pathologic complete response in neoadjuvant chemotherapy
Cancer Research·2023
Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy
Cancers·2022· 20 citedOpen Access
Disease and Treatment Monitoring
Elsevier eBooks·2022
Expert tumor annotations and radiomics for locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1
Scientific Data·2022· 15 citedOpen Access
Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer
Tomography·2022· 6 citedOpen Access
Impact of deformable registration methods for prediction of recurrence free survival response to neoadjuvant chemotherapy in breast cancer: Results from the ISPY 1/ACRIN 6657 trial
Translational Oncology·2022· 6 citedOpen Access
Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response
Tomography·2022· 4 citedOpen Access
Impact of Alternate b-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 Trial
Tomography·2022· 13 citedOpen Access
Abstract P3-03-08: Background parenchymal enhancement as an imaging biomarker in neoadjuvant endocrine therapy for DCIS
Cancer Research·2022
page 1 of 7Next →

Frequent Co-authors

Sharmila Majumdar(32), Thomas M. Link(16), Harry K. Genant(15), Nola M. Hylton(13), John C. Lin(9), Thomas L. Chenevert(7), Peter Augat(6), Laura J. Esserman(5), Ying Lü(5), Lisa J. Wilmes(5), S. Grampp(4), Savannah C. Partridge(4), Mark Rosen(4), Bonnie N. Joe(4), M. Jergas(4), Volker Vieth(4), Dariya Malyarenko(4), John Kornak(4), Patrick J. Bolan(3), Helga S. Marques(3)